-+ 0.00%
-+ 0.00%
-+ 0.00%

JP Morgan Upgrades Edwards Lifesciences to Overweight, Raises Price Target to $100

Benzinga·12/18/2025 13:40:27
Listen to the news
JP Morgan analyst Robbie Marcus upgrades Edwards Lifesciences (NYSE:EW) from Neutral to Overweight and raises the price target from $90 to $100.